What question did this study set out to answer?

This research aims to evaluate the performance of Oxford Nanopore sequencing technologies in clinical genomics applications.

February 13, 2026Genome Research

Assessing the readiness of Oxford Nanopore sequencing for clinical genomics applications

View Full Paper

Ask AI

Bookmark

Authors

This assessment compares Oxford Nanopore's performance to other technologies, indicating its readiness for clinical use.

This research aims to evaluate the performance of Oxford Nanopore sequencing technologies in clinical genomics applications.
Comparison of ONT with Illumina and MGI on 17 reference samples.
Implementation of a production-ready pipeline for variant detection including SNV, indel, and SV.
Sanger validation of detected variants alongside multiplatform analysis.
ONT shows high accuracy for SNVs (F-score 0.978–0.983) and SVs (F-score 0.75).
Weakness in detecting indels, with F-scores ranging from 0.659 to 0.758.
All pathogenic indels were accurately detected, showcasing performance improvement with R10 chemistry.

Arres et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark